Replicase polyprotein 1a (pp1a) (pp1a)

Replicase polyprotein 1a (pp1a) is a multifunctional viral protein essential for coronavirus replication and transcription[4][6]. The pp1a polyprotein, typically 4,405 amino acids in length (or extended to 7,096 amino acids as pp1ab through ribosomal frameshift), is produced by translation of open reading frames 1a and 1b from the coronavirus genomic RNA[1][7]. Upon translation, pp1a undergoes proteolytic self-cleavage to generate 11-16 non-structural proteins (nsp1-nsp16) that collectively perform all functions necessary for viral RNA synthesis and processing[1][5][7]. These include the main protease (Mpro/nsp5) and papain-like protease (PL-pro/nsp3), which are responsible for processing the polyprotein itself, as well as enzymatic domains involved in RNA-dependent RNA polymerase activity, primer synthesis, and mRNA capping[5]. Beyond replication functions, pp1a also suppresses host innate immune responses through mechanisms including IRF3 and NF-κB pathway blockade[5]. As a critical component of the viral replication machinery, pp1a is an important therapeutic target for antiviral drug development, with protease inhibitors representing a major class of coronavirus therapeutics[2][5].

Other names

Replicase polyprotein 1ab (pp1ab) - the extended form produced via ribosomal frameshiftReplicase/transcriptasePolymeraseORF1a and ORF1b gene products

Protease inhibition targeting the main protease (Mpro/nsp5) cleavage sites within the polyprotein; Papain-like protease (PL-pro/nsp3) inhibition; Blockade of viral replication and transcription